Industry landscapes
The companies, capital and talent shaping pet tech in the United States. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
Recently founded means a recorded 2023–2026 founding year and no recorded parent, acquirer or public-company status. These companies are not labelled startups without that separate classification.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
28 of 495 tracked companies have open roles.
142 of 495 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 259 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 36.7% of disclosed capital, while 71.3% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $200.57M | 35 | 23 |
| 2017 | $168.35M | 27 | 18 |
| 2018 | $638.05M | 31 | 20 |
| 2019 | $463.82M | 36 | 32 |
| 2020 | $111.96M | 42 | 19 |
| 2021 | $241.19M | 32 | 24 |
| 2022 | $208.63M | 23 | 28 |
| 2023 | $166.25M | 7 | 23 |
| 2024 | $81.17M | 9 | 14 |
| 2025 | $62.77M | 0 | 9 |
Share of all disclosed company funding.
307 recorded rounds since 2016
Recorded participation in pet tech company rounds since 2016.
Backed by T. Rowe Price and Winslow Capital and others.
Backed by L Catterton.
Backed by Spark Capital and Menlo Ventures and others.
Backed by F-Prime Capital and Novo Holdings and others.
Backed by August Capital and RRE Ventures and others.
Participating investors were not recorded in this snapshot.
Backed by Madrona and Menlo Ventures and others.
Backed by Battery Ventures.
Backed by Insight Partners and Forerunner Ventures and others.
Backed by L Catterton.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2025 · company accounts; aggregate reporting threshold not met · 2 reporting entities from 5 eligible matches.
Sum of reporting-entity revenue; not the United States market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
None of 2 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2025 · 2 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| Freshpet ↗1611647 | $1,102.0m | $139.1m | +12.6% | — | — |
| 1-800-PetMeds ↗1040130 | $227.0m | $-6.3m | -2.8% | — | — |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the the United States companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
18 of the 495 companies on this page carry a measured traffic record (3.6%); these are the largest of those, by monthly visits. The median among them is 221,862 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| Roverrover.com | 5,740,253 | 70 | 74.1% |
| The Farmer\'s Dogthefarmersdog.com | 4,629,206 | 61 | 92.4% |
| 1-800-PetMeds1800petmeds.com | 785,826 | 58 | 74.7% |
| Wisdom Panelwisdompanel.com | 677,912 | 55 | 87.1% |
| Dog is Humandogishuman.com | 666,999 | 35 | 89.4% |
| ASPCAaspcapetinsurance.com | 443,191 | 61 | 64.7% |
| Zoetiszoetis.com | 319,120 | 47 | 67.9% |
| JustFoodForDogsjustfoodfordogs.com | 242,735 | 46 | 70.5% |
| Pumpkinpumpkin.care | 241,189 | 56 | 68.4% |
| PetBackerpetbacker.com | 202,535 | 43 | 71.9% |
Visits and authority are third-party web estimates, not company-reported figures.
46 of these companies (9.3%) publish at least one Android app — 75 apps in all, carrying 13.6M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| Rover - Dog Boarding & WalkingRover | 6.1M | 4.6 | Travel & Local |
| Wag! - Dog Walkers & SittersWag! | 2.2M | 3.7 | Travel & Local |
| PetBacker-Dog Boarding, SitterPetBacker | 1.1M | 4.2 | Lifestyle |
| Pawshake - Dog & Cat SitterPawshake | 781.9K | 3.8 | Travel & Local |
| VitusVet: Pet Health Care AppVitusVet | 385.2K | 4.6 | Medical |
| PawscoutPawscout | 366.9K | 3.3 | Lifestyle |
| Fi - GPS Dog TrackerFi | 327.4K | 3 | Health & Fitness |
| PetCheck MSD AHMSD Animal Health | 314.2K | — | Productivity |
| Pawp: 24/7 Vet & Pet CarePawp | 286.5K | 4.7 | Medical |
| Fetch Pet InsuranceFetch by the Dodo | 206.8K | 4.7 | Lifestyle |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q3–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Pet Tech | 53 | 12.8M | Rover - Dog Boarding & Walking 6.1M | |
| Local Services | 23 | 11.5M | Wag! - Dog Walkers & Sitters 2.2M | |
| Veterinary Healthtech | 26 | 1.6M | VitusVet: Pet Health Care App 385.2K | |
| Wearable Technology | 31 | 946.5K | Pawscout 366.9K | |
| Internet First Insurance Platforms | 11 | 709.2K | Fetch Pet Insurance 206.8K | |
| Consumer Electronics E-Commerce | 6 | 437.1K | Fi - GPS Dog Tracker 327.4K | |
| Professional Consumer Services | 3 | 110.7K | Petzey 101.1K | |
| Pet Care Products | 6 | 109.8K | Dogtra Pathfinder 70.7K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 71 of 75 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
20 companies hiring · $2.24B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
Ares is acquiring a 32.4% stake in Rover from Blackstone.
DJ Symrise invests in US animal nutrition biotech Bond Pet Foods.
Zoetis Inc., a leading animal health company headquartered in Parsippany, announced that it has entered into a definitive agreement with Neogen Corporation to acquire its animal genomics business for $160 million, subject to customary closing adjustments.
Canadian pet-food business Pure Treats has acquired peer Primal Pet Foods from private-equity firm Kinderhook Industries.
Cardone Ventures, backed by billionaire investor, Grant Cardone and his business partners Brandon and Natalie Dawson, today announced that it has submitted an unsolicited, non‑binding proposal to acquire PetMed Express, Inc. (Nasdaq: PETS ) (“PetMeds”) for $4.25 per share in cash, representing an implied equity value of approximately $89 million.
In April, the company invested in veterinary biopharmaceutical company VETmAb Biosciences.
previous funding rounds raised $46 million to support Jinx’s brick-and-mortar retail launch and expand its product portfolio.
Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, announced the successful closing of its $18 million Series B financing.
Bethencourt, whose company Wild Earth was acquired out of bankruptcy by InvenTel.
Koala Health, a Boston‑based digital pet health company, raised $20 million in Series B funding to expand its mobile‑first pharmacy and veterinary care platform.
Top 10 categories among 162 recorded events in the 24-month window.
2 companies with recorded IPO activity
IPO1 reports
IPO1 reports
7 tracked people moves
Appointment Senior Vice President of Supply Chain
Appointment Chief Financial Officer
Appointment Senior Vice President of Finance
Appointment Board of Directors
Appointment Chief Operating Officer
Products, platforms and features in the recorded window
Dog Food
Dog Food
Dog food
Pet treats
Pet treats
3 recorded events
Equity award approved under NASDAQ Listing Rule 5635(c)(4)NASDAQ
conditionally approved for saleFDA
Approval of equity awardNASDAQ
2 tracked suits
securities law violations, false and/or misleading statementsClass Action ·
misleading conduct and unlicensed financial servicesRegulatory · Verdict
Reported company results in the recorded window.
Median across 66 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| Northern Star Acquisition→BarkBox ↗ | Completed | 2026-06-01 | $1.6B |
| ares management→Rover ↗ | Announced | 2026-04-29 | Not stated in snapshot |
| Zoetis→neogen | Announced | 2026-03-03 | $160.0M |
| Pure Treats→Primal Pet Foods ↗ | Completed | 2026-02-23 | Not stated in snapshot |
| kinderhook industries→Primal Pet Foods ↗ | Completed | 2026-02-20 | Not stated in snapshot |
| cardone ventures→1-800-PetMeds ↗ | Announced | 2025-12-16 | $89.0M |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
878 postings in the preceding 12 months. The full 1,452-posting snapshot covers 50 employers.
9 tracked postings mention remote work.
548 postings specify a level.
Top skills across 1,452 tracked postings in the available jobs snapshot.
Median across 124 postings with pay data, expressed in USD.
| Company | Employees |
|---|---|
| Zoetis ↗ | 9,200 |
| Physicians Mutual ↗ | 1,629 |
| Freshpet ↗ | 779 |
| JustFoodForDogs ↗ | 500 |
| The Farmer\'s Dog ↗ | 355 |
| Cronus Pharma ↗ | 350 |
| 1-800-PetMeds ↗ | 212 |
| Fetch by the Dodo ↗ | 210 |
252 founders and chief executives across 197 companies.
Ex-L Catterton, Leslie's Poolmart, West Marine. Gonzaga University - School of Business Administration BBA 1990…
Invetx, ex-Nexvet Biopharma, ex-Elanco, Columbia Business School, 2007
Ex-Medicus Biosciences, SciStem, Vet-Stem, Merial, Black Horse Enterprises. University of Pennsylvania School of Medicine PHD
Ex-Co-Founder Retention Logic, Lootsie, Friendcard, Creative Artists Agency. USC Marshall School of Business BS 2009
Jinx, ex-Outdoor Voices, ex-Casper, Saint Francis University, 2007
Lynn University BA, Penn State University
Founder iAccelerate, BABEL.Ventures, ex-Alix Ventures, Wild Earth, IndieBio, Berkeley BioLabs. Reed College BA, Princeton University PhD
Companion Protect, Stray Dog Capital, Asurion, ex-DST Systems. Eastern Illinois University BA 1987
Ex-J.P. Morgan, Johnson & Johnson. Stanford University MSc 2006, Harvard Business School MBA 2013
Ex-Catterton, ex-McKinsey & Company, Geosyntec Consultants. Massachusetts Institute of Technology BS 2010
Fi Hq, ex-Handy Hq, ex-Square, The University of Chicago Booth School of Business, 2010
Hongik University, ex- Seoul National University. Korea Advanced Institute of Science and Technology 2007, Seoul National University 2009
38 profiles with education records.
5 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
2,188,952 articles in the measured 12-month window.
Pet Tech coverage across United States · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 482,051 |
| 2021Q3 | 507,556 |
| 2021Q4 | 482,380 |
| 2022Q1 | 524,899 |
| 2022Q2 | 516,701 |
| 2022Q3 | 529,547 |
| 2022Q4 | 589,113 |
| 2023Q1 | 612,973 |
| 2023Q2 | 611,458 |
| 2023Q3 | 548,891 |
| 2023Q4 | 515,270 |
| 2024Q1 | 536,560 |
| 2024Q2 | 519,411 |
| 2024Q3 | 508,171 |
| 2024Q4 | 536,142 |
| 2025Q1 | 802,003 |
| 2025Q2 | 550,992 |
| 2025Q3 | 1,298,896 |
| 2025Q4 | 280,698 |
| 2026Q1 | 396,946 |
| 2026Q2 | 212,412 |
Article volume measures coverage, not market sales.
329 recorded company events across 34 companies; percentages use that event total.
Pet Tech coverage across United States · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
Pet Tech coverage across United States
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| countries | 3,925 | 1,959 | 100% |
| etf trading | 2,577 | 1,059 | 143% |
| oil price volatility | 2,570 | 1,129 | 128% |
| etfs | 2,161 | 874 | 147% |
| sector etfs | 2,049 | 838 | 145% |
| etf products | 1,967 | 758 | 159% |
| etf structures | 1,870 | 739 | 153% |
| export sanctions | 1,743 | 617 | 182% |
| commodity trading | 1,700 | 686 | 148% |
| gold spot price | 1,608 | 797 | 102% |
| tariff negotiations | 12,626 | 20,938 | -40% |
| free trade deals | 5,294 | 8,451 | -37% |
| stock price | 2,352 | 3,857 | -39% |
| trade enforcement | 1,984 | 3,240 | -39% |
| economic slowdown | 1,505 | 2,887 | -48% |
Pet Tech coverage across United States
territories, disputed islands, tariff negotiations
41.2% critical · 20.3% positiveinvestment deal, inflation reports fx, currency intervention policies
44.7% critical · 40.8% positiveearnings report, quarterly results, quarterly financials
35.7% critical · 44.2% positivePet Tech coverage across United States. Topic labels describe recorded classifications and can include broad context.
6,260 papers in the recorded india scope.
Tone counts: 5,526 positive · 456 neutral · 278 negative.
Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob
Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases
Landmark: U1 snRNP regulates cancer cell migration and invasion in vitro
Common problems researchers identify · 0118.4% of this theme group
Researchers highlight hurdles in scaling microbial enzymes, synthetic biology, and nanotech for pet product biomanufacturing.
Biochemical engineering (18) · Synthetic biology (12) · Biomanufacturing (8) · Nanotechnology (9)
Microbial Enzymes: Tools for Biotechnological Processes
Medical biofilms
| Year | Share index |
|---|---|
| 2022 | 65.5 |
| 2023 | 67.5 |
| 2024 | 82.8 |
| 2025 | 67.2 |
Common problems researchers identify · 0215.7% of this theme group
Studies flag contamination and mycotoxin threats to pet food safety and public health.
Public health (15) · Mycotoxin (8) · Disease (12) · Contamination (8)
The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities
A review of Listeria monocytogenes: An update on outbreaks, virulence, dose-response, ecology, and risk assessments
| Year | Share index |
|---|---|
| 2022 | 285.1 |
| 2023 | 250.5 |
| 2024 | 257.0 |
| 2025 | 271.4 |
Common problems researchers identify · 0315.5% of this theme group
Papers discuss mutation, DNA methylation, and cancer‑related mechanisms affecting animal health.
Mutation (7) · Cancer (9) · DNA methylation (5) · Gene (8)
Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research
Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine
| Year | Share index |
|---|---|
| 2022 | 985.7 |
| 2023 | 1214.2 |
| 2024 | 880.5 |
| 2025 | 812.4 |
Common problems researchers identify · 0415.2% of this theme group
Research points to difficulties in engineering crops for abiotic stress tolerance relevant to pet feed.
Agriculture (33) · Abiotic stress (10) · Abiotic component (12) · Biotechnology (20)
Genetic Engineering for Modern Agriculture: Challenges and Perspectives
Phytohormones and their metabolic engineering for abiotic stress tolerance in crop plants
| Year | Share index |
|---|---|
| 2022 | 1493.3 |
| 2023 | 1526.3 |
| 2024 | 1687.0 |
| 2025 | 1881.5 |
Common problems researchers identify · 0514.7% of this theme group
Authors note obstacles in enhancing micronutrient content and food‑science processes for pet nutrition.
Micronutrient (9) · Production (13) · Nutrient (10) · Food science (7)
Improving nutrition through biofortification: A review of evidence from HarvestPlus, 2003 through 2016
Food fermentations: Microorganisms with technological beneficial use
| Year | Share index |
|---|---|
| 2022 | 121.0 |
| 2023 | 117.3 |
| 2024 | 113.6 |
| 2025 | 123.0 |
Common problems researchers identify · 0611.1% of this theme group
Works emphasize rising antibiotic resistance in microbes affecting pet health and treatment options.
Antibiotic resistance (49) · Antimicrobial (31) · Antibiotics (22) · Drug resistance (8)
An overview of the antimicrobial resistance mechanisms of bacteria
The global threat of antimicrobial resistance: science for intervention
| Year | Share index |
|---|---|
| 2022 | 899.0 |
| 2023 | 850.6 |
| 2024 | 928.8 |
| 2025 | 985.9 |
Common problems researchers identify · 079.5% of this theme group
Studies raise concerns about insecticide resistance and integrated pest management for pet‑related agriculture.
Resistance (14) · Insecticide resistance (5) · Vector (5) · Integrated pest management (5)
Insecticide Resistance in Mosquitoes: Impact, Mechanisms, and Research Directions
Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens
| Year | Share index |
|---|---|
| 2022 | 3.3 |
| 2023 | 3.1 |
| 2024 | 4.4 |
| 2025 | 4.2 |
Cautions · 0124.6% of this theme group
Researchers urge caution interpreting DNA repair and mutation data for veterinary applications.
DNA repair (7) · DNA polymerase (6) · DNA damage (7) · Mutation (9)
Examining the link between chromosomal instability and aneuploidy in human cells
Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations
| Year | Share index |
|---|---|
| 2022 | 102.6 |
| 2023 | 141.1 |
| 2024 | 93.5 |
| 2025 | 80.8 |
Cautions · 0218.1% of this theme group
Papers caution about unintended immune effects of antibody therapies in animal models.
Antibody (9) · In vivo (8) · Peripheral blood mononuclear cell (4) · Immune system (5)
Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs
T cell responses towards PINK1 and ⍺-synuclein are elevated in prodromal Parkinson's disease - Fluorospot data
| Year | Share index |
|---|---|
| 2022 | 550.6 |
| 2023 | 610.2 |
| 2024 | 456.2 |
| 2025 | 450.6 |
Cautions · 0314.4% of this theme group
Authors advise careful assessment of raw material additives and sugar impacts on pet food safety.
Food safety (6) · Raw material (4) · Health benefits (4) · Sugar (3)
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
Soybean susceptibility to manufactured nanomaterials with evidence for food quality and soil fertility interruption
| Year | Share index |
|---|---|
| 2022 | 116.7 |
| 2023 | 113.4 |
| 2024 | 108.9 |
| 2025 | 136.7 |
Cautions · 0411.6% of this theme group
Research warns of variable outcomes from tannin or mineral supplements in dairy and beef production.
Dairy cattle (6) · Production (6) · Nutrient (6) · Beef cattle (5)
Impact of tannin-based additives on animal performance and enteric methane emissions in dairy and beef cattle: A meta-analysis
The effects of injectable trace mineral solutions on beef cattle performance and health during preconditioning and feedlot receiving: a syst
| Year | Share index |
|---|---|
| 2022 | 127.6 |
| 2023 | 123.1 |
| 2024 | 119.4 |
| 2025 | 130.6 |
Cautions · 0510.8% of this theme group
Studies highlight uncertainties in applying genomic selection for trait improvement in pets and livestock.
Gene (10) · Genomic selection (5) · Selection (6) · Trait (4)
Genomic Selection for Crop Improvement
Genomic selection in plant breeding: from theory to practice
| Year | Share index |
|---|---|
| 2022 | 2399.2 |
| 2023 | 2383.4 |
| 2024 | 2116.6 |
| 2025 | 1600.6 |
Cautions · 0610.5% of this theme group
Authors note potential drawbacks of fungal endophytes and pesticide resistance in pest control programs.
PEST analysis (9) · Agriculture (7) · Pest control (3) · Integrated pest management (3)
The use of fungal entomopathogens as endophytes in biological control: a review
Insecticide Control of Vector-Borne Diseases: When Is Insecticide Resistance a Problem?
| Year | Share index |
|---|---|
| 2022 | 1464.0 |
| 2023 | 1506.4 |
| 2024 | 1673.1 |
| 2025 | 1869.5 |
Cautions · 079.9% of this theme group
Papers caution about antimicrobial overuse in animal husbandry fostering resistant bacterial populations.
Antibiotic resistance (12) · Antibiotics (9) · Antimicrobial (6) · Bacteria (5)
Multidrug evolutionary strategies to reverse antibiotic resistance
Impact of Antibiotic Use in Adult Dairy Cows on Antimicrobial Resistance of Veterinary and Human Pathogens: A Comprehensive Review
| Year | Share index |
|---|---|
| 2022 | 899.0 |
| 2023 | 850.6 |
| 2024 | 928.8 |
| 2025 | 985.9 |
Opportunities · 0119.6% of this theme group
Research explores beneficial microbes and their metabolites to improve pet health and food quality.
Antimicrobial (64) · Fermentation (55) · Bacteria (52) · Antibiotic resistance (37)
Probiotics, their health benefits and applications for developing healthier foods: a review
Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance
| Year | Share index |
|---|---|
| 2022 | 2441.1 |
| 2023 | 2274.4 |
| 2024 | 2358.9 |
| 2025 | 2001.2 |
Opportunities · 0219.3% of this theme group
Studies identify gene knockdown and apoptosis pathways as targets for novel veterinary treatments.
Apoptosis (37) · Downregulation and upregulation (57) · Gene knockdown (46) · Mutant (48)
PCBP1 binding to single-stranded poly-cytosine motifs enhances cGAS sensing and impairs breast cancer development
Modulation of ossification and inflammatory pathways during dexamethasone-induced <i>in vitro</i> osteogenesis
| Year | Share index |
|---|---|
| 2022 | 368.7 |
| 2023 | 400.0 |
| 2024 | 261.5 |
| 2025 | 267.4 |
Opportunities · 0313.2% of this theme group
Works highlight T‑cell and antigen engineering for advanced disease interventions in animals.
Cell culture (77) · T cell (54) · Antigen (49) · Cell (62)
CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
| Year | Share index |
|---|---|
| 2022 | 293.0 |
| 2023 | 340.3 |
| 2024 | 228.5 |
| 2025 | 208.3 |
Opportunities · 0412.8% of this theme group
Research points to DNA repair and methylation tools for correcting genetic disorders in pets.
DNA repair (65) · DNA damage (68) · DNA methylation (58) · DNA replication (34)
Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders
MacroH2A-Mediated Gene Repression through Nucleosome Compaction and Remodeling Inhibition
| Year | Share index |
|---|---|
| 2022 | 227.2 |
| 2023 | 285.7 |
| 2024 | 199.8 |
| 2025 | 161.5 |
Opportunities · 0512.2% of this theme group
Papers present fluorescent and molecular imaging nanoparticles for real‑time diagnostics in veterinary medicine.
In vivo (142) · Fluorescence (41) · Molecular imaging (28) · Nanotechnology (33)
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticl
| Year | Share index |
|---|---|
| 2022 | 486.8 |
| 2023 | 527.9 |
| 2024 | 404.3 |
| 2025 | 415.7 |
Opportunities · 0611.7% of this theme group
Studies promote germplasm sequencing and selection to enhance genetic diversity of pet‑relevant crops.
Germplasm (37) · Selection (42) · Genetic diversity (28) · Trait (28)
Genotyping‐by‐Sequencing for Plant Breeding and Genetics
Harvesting the Promising Fruits of Genomics: Applying Genome Sequencing Technologies to Crop Breeding
| Year | Share index |
|---|---|
| 2022 | 56.7 |
| 2023 | 52.1 |
| 2024 | 46.9 |
| 2025 | 54.3 |
Opportunities · 0711.3% of this theme group
Research advances mRNA, microRNA, and transcriptional control strategies for targeted animal therapies.
Messenger RNA (103) · microRNA (61) · Transcription (65) · RNA polymerase II (34)
m <sup>6</sup> A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation
Microrna-Dependent Regulation of Dna Methyltransferase-1 and Tumor Suppressor Gene Expression by Interleukin-6 in Human Malignant Cholangioc
| Year | Share index |
|---|---|
| 2022 | 232.1 |
| 2023 | 198.5 |
| 2024 | 159.9 |
| 2025 | 139.2 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Breakthrough | 32.6% | 26.2% |
| Promising | 31.0% | 37.4% |
| Descriptive | 17.5% | 17.3% |
| Problem-identifying | 9.1% | 9.7% |
| Cautionary | 5.8% | 4.6% |
| Comparative | 2.8% | 3.9% |
| Critical | 1.3% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities | 18 | 0.3% | 2 (11.1%) | 0.21% |
| Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste | 4 | 0.07% | 1 (25.0%) | 0.15% |
| Bias & fairnessNot All Allies Are Welcome: Partner Discrimination in Legume–Rhizobium Symbiosis | 3 | 0.05% | 1 (33.3%) | 0.03% |
| Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya | 1 | 0.02% | 1 (100.0%) | 0.01% |
| Energy & datacenter footprint | 0 | 0.0% | 0 (%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
| Carbon & emissions of compute | 0 | 0.0% | 0 (%) | 0.0% |
| Labour & data work | 0 | 0.0% | 0 (%) | 0.0% |
| Concentration of compute power | 0 | 0.0% | 0 (%) | 0.0% |
Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.
Institution and researcher rankings use citations to their covered work. Research scope: United States. This may be broader than the company geography.
Published patent filings in the recorded source window.
Company counts, hiring and disclosed funding across the recorded hubs.
24.3% across the displayed hubs
3 companies hiring · $337.3M disclosed funding
Explore companies in New York City ↗23.3% across the displayed hubs
0 companies hiring · $80.6M disclosed funding
Explore companies in San Francisco ↗10.7% across the displayed hubs
0 companies hiring · $512.2M disclosed funding
Explore companies in Los Angeles ↗
9.7% across the displayed hubs
0 companies hiring · $21.6M disclosed funding
Explore companies in Chicago ↗9.7% across the displayed hubs
0 companies hiring · $32.3M disclosed funding
Explore companies in San Diego ↗
7.8% across the displayed hubs
1 companies hiring · $0 disclosed funding
Explore companies in Austin ↗
7.8% across the displayed hubs
0 companies hiring · $1.2M disclosed funding
Explore companies in Seattle ↗
6.8% across the displayed hubs
0 companies hiring · $2.1M disclosed funding
Explore companies in Miami ↗Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 2 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗